| Dr Bruce Raymond Bush, MD | |
|
814 Cloverview Dr, Glendora, CA 91741-1916 | |
| (562) 809-6978 | |
| Not Available |
| Full Name | Dr Bruce Raymond Bush |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 814 Cloverview Dr, Glendora, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548202476 | NPI | - | NPPES |
| 00G481950 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G48195 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bruce Raymond Bush, MD 814 Cloverview Dr, Glendora, CA 91741-1916 Ph: (562) 809-6978 | Dr Bruce Raymond Bush, MD 814 Cloverview Dr, Glendora, CA 91741-1916 Ph: (562) 809-6978 |
News Archive
The Marburg virus, a relative of the Ebola virus, causes a serious, often-fatal hemorrhagic fever. Transmitted by the African fruit bat and by direct human-to-human contact, Marburg virus disease currently has no approved vaccine or antivirals to prevent or treat it.
As announced on August 11, 2014, Twinlab Consolidation Corporation completed its first transaction with the acquisition of Twinlab Corporation. Today, TCC announces the successful completion of its merger into Twinlab Consolidated Holdings Inc., resulting in TCC becoming a wholly-owned subsidiary of TLCC.
The unchecked advance of COVID-19 has made it a top public health priority to produce a vaccine capable of inducing a safe and powerful protective response against its causative pathogen: SARS-CoV-2. An encouraging new study shows the immunogenicity, safety, and protective efficacy, of a Newcastle disease virus (NDV)-based intranasal vector vaccine in animal studies.
AVEO Pharmaceuticals, Inc. and Boehringer Ingelheim today announced that they have entered into an agreement for large-scale process development and clinical manufacturing of ficlatuzumab, AVEO's novel HGF inhibitory antibody that is currently in Phase 2 clinical development in patients with non-small cell lung cancer.
› Verified 4 days ago
Dr. Erick Douglas Stone, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 401 E Laurel Ave, Glendora, CA 91741 Phone: 626-963-4243 Fax: 626-963-0051 | |
Leonard Y Herman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 S Grand Ave, Glendora, CA 91741 Phone: 626-840-5655 Fax: 626-287-1940 | |
Earl Scott Isbell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 250 S Grand Ave, Glendora, CA 91741 Phone: 626-857-3170 | |
Dr. Michael Bogey, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 150 W Route 66, Emergency Department, Glendora, CA 91740 Phone: 626-852-6119 | |
Dr. Eric Brown, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 148 N Grand Ave, Glendora, CA 91741 Phone: 626-594-0478 Fax: 626-594-0575 | |
Dr. Michael D Deyoung, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 250 S Grand Ave, Glendora, CA 91741 Phone: 626-857-3170 |